Paper3142013
Resistance to imipenem in Pseudomonas aeruginosa: clinical experience and biochemical mechanisms.
Quinn JP and 3 others. Rev Infect Dis, 1988. Cited by 70 papers, by iCite.
Cite this record
ConductScience Library. Resistance to imipenem in Pseudomonas aeruginosa: clinical experience and biochemical mechanisms. Papers, record 3142013. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3142013
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Imipenem | Major topic |
| Pseudomonas Infections | Major topic |
| Pseudomonas aeruginosa | Major topic |
| Drug Resistance, Microbial | |
| Humans | |
| beta-Lactamases |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| AI-07099 | NIAID NIH HHS | United States | PubMed |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT01570192 | Clinical Trials to Reduce the Risk of Antimicrobial Resistance | Background |
Source ClinicalTrials.gov
Cited by15
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 70 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42598182 | Pharmacodynamic modeling of colistin and imipenem against in vitro Pseudomonas aeruginosa biofilms. | Biofilm | 2026 | https://conductscience.org/library/papers/42598182 | PubMed |
| 24336826 | In memoriam: John P. Quinn, MD. | Clin Infect Dis | 2014 | https://conductscience.org/library/papers/24336826 | PubMed |
| 19822890 | Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms. | Clin Microbiol Rev | 2009 | https://conductscience.org/library/papers/19822890 | PubMed |
| 18983709 | Clinical review: balancing the therapeutic, safety, and economic issues underlying effective antipseudomonal carbapenem use. | Crit Care | 2008 | https://conductscience.org/library/papers/18983709 | PubMed |
| 16517923 | Treatment failure due to emergence of resistance to carbapenem during therapy for Shewanella algae bacteremia. | J Clin Microbiol | 2006 | https://conductscience.org/library/papers/16517923 | PubMed |
| 15561840 | Molecular characterization of a beta-lactamase gene, blaGIM-1, encoding a new subclass of metallo-beta-lactamase. | Antimicrob Agents Chemother | 2004 | https://conductscience.org/library/papers/15561840 | PubMed |
| 8408557 | Influence of zinc on Pseudomonas aeruginosa susceptibilities to imipenem. | J Clin Microbiol | 1993 | https://conductscience.org/library/papers/8408557 | PubMed |
| 8141574 | Retain intermittent dosing of carbapenems. | Antimicrob Agents Chemother | 1994 | https://conductscience.org/library/papers/8141574 | PubMed |
| 8117090 | Chemotaxis to oligopeptides by Pseudomonas aeruginosa. | Appl Environ Microbiol | 1994 | https://conductscience.org/library/papers/8117090 | PubMed |
| 8050431 | Imipenem resistance among gram-negative bacilli. | Eur J Clin Microbiol Infect Dis | 1994 | https://conductscience.org/library/papers/8050431 | PubMed |
| 7726503 | Activity of carbapenem BMS-181139 against Pseudomonas aeruginosa is not dependent on porin protein D2. | Antimicrob Agents Chemother | 1995 | https://conductscience.org/library/papers/7726503 | PubMed |
| 7648757 | Meropenem clinical pharmacokinetics. | Clin Pharmacokinet | 1995 | https://conductscience.org/library/papers/7648757 | PubMed |
| 2109575 | Outer membrane protein D2 catalyzes facilitated diffusion of carbapenems and penems through the outer membrane of Pseudomonas aeruginosa. | Antimicrob Agents Chemother | 1990 | https://conductscience.org/library/papers/2109575 | PubMed |
| 2039198 | Pseudomonas pseudomallei, a common pathogen in Thailand that is resistant to the bactericidal effects of many antibiotics. | Antimicrob Agents Chemother | 1991 | https://conductscience.org/library/papers/2039198 | PubMed |
| 1645509 | Resistance to pefloxacin in Pseudomonas aeruginosa. | Antimicrob Agents Chemother | 1991 | https://conductscience.org/library/papers/1645509 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3142013
GET https://conductscience.org/api/papers/v1/3142013/authors